The Bell2Bell (B2B) Podcast

Bell2Bell’s latest podcast features Howard Weisman, Chairman and CEO of PaxMedica, Inc. (Nasdaq: PXMD), along with Buzz Woods from Corporate Communications, who join the podcast to share insights into the biopharmaceutical company's groundbreaking work in novel anti-purinergic drug therapies (APT) for neurologic conditions, primarily Autism Spectrum Disorder (ASD). Explore the comprehensive interv...

Bell2Bell’s latest podcast features Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.   This episode was recorded live at the venue hosting the 2023 American Association for Cancer Research Conference for Molecular Targets and Cancer Therapeutics, o...

Bell2Bell’s latest podcast features Howard Weisman, Chairman and CEO of PaxMedica, Inc. (Nasdaq: PXMD), along with Buzz Woods from Corporate Communications, who join the podcast to share insights into the biopharmaceutical company's groundbreaking work in novel anti-purinergic drug therapies (APT) for neurologic conditions, primarily Autism Spectrum Disorder (ASD). Explore the comprehensive interv...

Bell2Bell’s latest podcast features Rob Etherington, President and CEO of Clene Inc. , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. To begin the interview, Etherington provided an introduction to Clene’s business model and discussed recent developments providing hope to those affected...

Bell2Bell’s latest podcast features Rob Etherington, President and CEO of Clene Inc. , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. To begin the interview, Etherington provided an introduction to Clene’s business model and discussed recent developments providing hope to those affected...

Bell2Bell’s latest podcast features Richard Clowater, President of GEMXX Corp. (OTC: GEMZ) , a mine-to-market enterprise specializing in gold, gemstone and jewelry production. To begin the interview, Clowater provided an introduction to Ammolite, an extremely rare gemstone of which GEMXX is a leading producer. “Ammolite is a very rare gemstone. It’s similar to black opal when you look at it; it’s...

Bell2Bell’s latest podcast features Richard Clowater, President of GEMXX Corp. (OTC: GEMZ) , a mine-to-market enterprise specializing in gold, gemstone and jewelry production. To begin the interview, Clowater provided an introduction to Ammolite, an extremely rare gemstone of which GEMXX is a leading producer. “Ammolite is a very rare gemstone. It’s similar to black opal when you look at it; it’s...

Bell2Bell’s latest podcast features Brien Lundin, CEO of New Orleans Investment Conference and Editor of Gold Newsletter . The New Orleans Investment Conference, scheduled for November 1-3, 2023, brings together the world’s most sophisticated investors to discover new opportunities and strategies, exchange ideas, plan for the coming year and enjoy the camaraderie of like-minded individuals.   Thro...

Bell2Bell’s latest podcast features Brien Lundin, CEO of New Orleans Investment Conference and Editor of Gold Newsletter . The New Orleans Investment Conference, scheduled for November 1-3, 2023, brings together the world’s most sophisticated investors to discover new opportunities and strategies, exchange ideas, plan for the coming year and enjoy the camaraderie of like-minded individuals.   Thro...

“Reunion Gold is a gold exploration company. Our activities are mainly focused around the Guiana Shield, which includes countries like French Guiana, Suriname and Guyana,” said Rick Howes, President & CEO of Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) . “We’ve been well established in [Guyana], and the team that’s leading the company today includes individuals...

“Reunion Gold is a gold exploration company. Our activities are mainly focused around the Guiana Shield, which includes countries like French Guiana, Suriname and Guyana,” said Rick Howes, President & CEO of Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) . “We’ve been well established in [Guyana], and the team that’s leading the company today includes individuals...

Bell2Bell’s latest podcast features Tyrone Docherty, President & CEO of First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) , a company committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets.  To begin the interview, Docherty provided an introduction to the company’s business model...

Bell2Bell’s latest podcast features Tyrone Docherty, President & CEO of First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) , a company committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets.  To begin the interview, Docherty provided an introduction to the company’s business model...

Bell2Bell’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) . BiondVax’s pipeline is based on an innovative platform technology of alpaca-derived nanosized antibodies, known as Nanobodies or NanoAbs, addressing infectious and autoimmune diseases with large unmet medical needs such as COVID-19, psoriasis, psoriatic arthritis, asthma and macular degeneratio...

Bell2Bell’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) . BiondVax’s pipeline is based on an innovative platform technology of alpaca-derived nanosized antibodies, known as Nanobodies or NanoAbs, addressing infectious and autoimmune diseases with large unmet medical needs such as COVID-19, psoriasis, psoriatic arthritis, asthma and macular degeneratio...

Bell2Bell’s latest podcast features Chairman, President and CEO Rodney Varner and CFO Ryan Confer of Genprex, Inc. (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.  In this interview, Varner and Confer discuss the journeys that led them to Genprex and the incredible promise of the company’s clinical d...

Bell2Bell’s latest podcast features Chairman, President and CEO Rodney Varner and CFO Ryan Confer of Genprex, Inc. (NASDAQ: GNPX) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.  In this interview, Varner and Confer discuss the journeys that led them to Genprex and the incredible promise of the company’s clinical d...

Bell2Bell’s latest podcast features Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes. This episode was recorded live at the venue hosting the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, the largest clinical oncology meeting of...

Bell2Bell’s latest podcast features Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes. This episode was recorded live at the venue hosting the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, the largest clinical oncology meeting of...

Bell2Bell’s latest podcast features Ross Sklar, CEO of Starco Brands, Inc. (OTCQB: STCB) , a company with an unwavering mission to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday. To begin the interview, Sklar provided an introduction to the company’s business model and operating markets. “Starco Brands is focused in consume...

Bell2Bell’s latest podcast features Ross Sklar, CEO of  Starco Brands, Inc. (OTCQB: STCB) , a company with an unwavering mission to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday. To begin the interview, Sklar provided an introduction to the company’s business model and operating markets. “Starco Brands is focused in consum...

Bell2Bell’s latest podcast features Paul Gorman, CEO and Director of Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) , a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space.  To begin the interview, Gorman provided an introduction to the company’s business model and operating markets.  “Reflex was really...

Bell2Bell’s latest podcast features Paul Gorman, CEO and Director of Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) , a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space.  To begin the interview, Gorman provided an introduction to the company’s business model and operating markets.  “Reflex was really...

Bell2Bell’s latest podcast features Eli Assoolin, CEO of Newsight Imaging. The company develops advanced CMOS image sensor chips for 3D machine vision and spectral analysis. Newsight’s depth camera sensors for machine vision serve verticals such as mobile & metaverse, robotics, and automotive safety. To begin the interview, Assoolin discussed his career and provided some background on Newsight Ima...

Bell2Bell’s latest podcast features Eli Assoolin, CEO of Newsight Imaging. The company develops advanced CMOS image sensor chips for 3D machine vision and spectral analysis. Newsight’s depth camera sensors for machine vision serve verticals such as mobile & metaverse, robotics, and automotive safety. To begin the interview, Assoolin discussed his career and provided some background on Newsight Ima...